San Diego, CA, United States of America

Aarthi Mahalingam

This inventor holds 98 USPTO granted patents and 60 published patent applications, plus 6 CIPO patents and 16 EPO patents, primarily in Continuous Glucose Monitoring (CPC class A61B5-14532). Top assignee: Dexcom, Inc.. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aarthi Mahalingam. Retrieved from https://idiyas.com/inventor/aarthi-mahalingam

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 98 

% Patents Active = 98.0

 

 

Average Co-Inventor Count = 5.8

ph-index = 26

Forward Citations = 2,655(Granted Patents)

Forward Citations (Not Self Cited) = 2,113(Dec 10, 2025)


Inventors with similar research interests:

🔬 See more inventors

Company Filing History:


Years Active: 2012-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Continuous Glucose Monitoring
Insulin Delivery System
Analyte Sensor
Glycemic Variability
Sensor Data Processing
Bolus Calculator
Data Calibration
Monitoring Communications
Sensor Support
Artifact Replacement
Analyte Monitoring
Continuous Analyte Monitoring
98 patents (USPTO):Explore Patents

Certainly! Here is an article about inventor Aarthi Mahalingam:

Title: Innovator Spotlight: Aarthi Mahalingam - Pioneering Continuous Analyte Monitoring

Introduction: Aarthi Mahalingam, a brilliant inventor based in San Diego, CA, is at the forefront of revolutionizing continuous analyte monitoring through his groundbreaking patents and innovative solutions.

Latest Patents: Aarthi Mahalingam holds an impressive total of 88 patents, with his latest inventions focused on enhancing the accuracy and efficiency of continuous analyte sensor data processing. His patents include systems and methods for applying time-dependent algorithmic compensation functions to data output from continuous analyte sensors, as well as for providing technical support for patients using medical devices like continuous glucose monitoring systems.

Career Highlights: Aarthi Mahalingam is a key figure at Dexcom, Inc., a leading company in the field of continuous glucose monitoring. His expertise and dedication have played a pivotal role in advancing the capabilities of medical devices for monitoring analytes, ultimately improving the quality of life for patients worldwide.

Collaborations: Aarthi Mahalingam collaborates closely with esteemed colleagues such as Apurv Ullas Kamath and James H Brauker at Dexcom, Inc. Together, they form a dynamic team driving innovation and excellence in the development of next-generation continuous analyte monitoring technologies.

Conclusion: In conclusion, Aarthi Mahalingam's prolific career as an inventor and his contributions to the field of continuous analyte monitoring exemplify his commitment to pushing the boundaries of innovation. His remarkable patents and collaborations stand as a testament to his impactful work in advancing medical technologies for the betterment of society.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…